Kidney transplant
Conditions
Interventions
Case series:None
Sponsors
The First Affiliated Hospital, Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Kidney transplant patients, age >=18 years; 2.Triple immunotherapy: tacrolimus + mycophenolate + glucocorticoid; 3.FK506 was taken orally on the second day after surgery, with an initial oral dose of 0.05-0.25 mg/(kg*d), divided into two oral doses, and the dosage was adjusted later according to blood concentration and other indications of patients.
Exclusion criteria
Exclusion criteria: 1.Patients who lost to follow-up; 2.Patients who discontinued tacrolimus after kidney transplantation for other reasons other than hyperglycemia; 3.Patients who failed to regularly monitor blood glucose and tacrolimus concentration data within 3 months after kidney transplantation; 4.A history of severe heart, lung, and liver sclerosis or malignancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| New diabetes after transplantation; | — |
Countries
China
Contacts
Public ContactHuang Mingzhu
The First Affiliated Hospital, Zhejiang University School of Medicine
Outcome results
None listed